USPTO Examiner MCCORMICK EWOLDT SUSAN BETH - Art Unit 1661

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18831797Hybrid Tea Rose Plant Named 'Poulpmt010'September 2025December 2025Allow300NoNo
18831799Miniature Rose Plant Named 'Poulpah 125'September 2025December 2025Allow300NoNo
19329242PHALAENOPSIS PLANT NAMED 'PHA329495'September 2025December 2025Allow300NoNo
19320567SHEPHERDIA PLANT NAMED 'TORREY'September 2025March 2026Allow610NoNo
19315581ANTHURIUM PLANT NAMED 'AN2181990'August 2025November 2025Allow300NoNo
19315587ANTHURIUM PLANT NAMED 'AN2541672'August 2025November 2025Allow300NoNo
19313539MANDEVILLA PLANT NAMED 'TVMD714'August 2025October 2025Allow200NoNo
19313675MANDEVILLA PLANT NAMED 'TVMD1626'August 2025December 2025Allow400NoNo
19313668MANDEVILLA PLANT NAMED 'TVMD1573'August 2025November 2025Allow200NoNo
19313653MANDEVILLA PLANT NAMED 'TVMD1330'August 2025November 2025Allow200NoNo
19313602MANDEVILLA PLANT NAMED 'TVMD982'August 2025October 2025Allow200NoNo
19310781HYBRID TEA ROSE PLANT NAMED 'ESM R895'August 2025October 2025Allow200NoNo
19307406HYBRID LIME PLANT NAMED 'C4-5-14'August 2025October 2025Allow200NoNo
19307802Calathea Plant Named 'HGV25'August 2025December 2025Allow400NoNo
19305681MUSHROOM VARIETY NAMED 'RO14176'August 2025February 2026Allow510NoNo
19305683MUSHROOM VARIETY NAMED 'RO12756'August 2025February 2026Allow510NoNo
18831749Lobelia plant named 'Neon Nights'August 2025December 2025Allow400NoNo
18831689Grapevine named 'SV34-134-463'July 2025November 2025Allow410NoNo
19235336Rudbeckia Plant Named 'BullRudihir 124'June 2025February 2026Allow910NoNo
19232186Rudbeckia Plant Named 'RUDBKST704'June 2025September 2025Allow400NoNo
19232228Rudbeckia Plant Named 'RUDBSS851'June 2025September 2025Allow400NoNo
19232300Rudbeckia Plant Named 'RUDLPIR734'June 2025September 2025Allow400NoNo
19232149Rudbeckia Plant Named 'RUDBBCH767'June 2025September 2025Allow400NoNo
19229555Dianthus Plant Named 'WP24 JAP01'June 2025September 2025Allow400NoNo
19229603Dracaena Plant Named 'Janet Lindo Gold'June 2025September 2025Allow400NoNo
19224785HELLEBORUS PLANT NAMED 'FLEVO 21-13-371'May 2025September 2025Allow300NoNo
19224780HELLEBORUS PLANT NAMED 'FLEVO 20-11-034'May 2025September 2025Allow300NoNo
19224782HELLEBORUS PLANT NAMED 'FLEVO 20-11-101'May 2025September 2025Allow300NoNo
19224787MENTHA PLANT NAMED 'ALLMEFRESHIMP'May 2025September 2025Allow300NoNo
19217077PETUNIA PLANT NAMED 'PEHY0090'May 2025August 2025Allow300NoNo
18831590NECTARINE TREE Named 'Mike's Fire'May 2025August 2025Allow300NoNo
19202503Pelargonium Plant Named 'KLEPZ24874'May 2025July 2025Allow200NoNo
19200404Laurel Plant Named 'GREAWL'May 2025August 2025Allow300NoNo
19194202Clematis Plant Named 'EviGsy154'April 2025July 2025Allow300NoNo
18831569Heliopsis plant named 'Rays for Days'April 2025December 2025Allow810NoNo
19189836STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDELEVEN'April 2025October 2025Allow610NoNo
19185633Hibiscus Plant Named 'Walhideli'April 2025September 2025Allow510NoNo
19186008Hydrangea plant named 'SC-04-20'April 2025October 2025Allow610NoNo
19185512Tillandsia plant named 'Preziosa'April 2025September 2025Allow510NoNo
19182744Clematis Plant Named 'EviGsy155'April 2025June 2025Allow200NoNo
18831558Alocasia Plant Named 'HUTAAL29'April 2025August 2025Allow400NoNo
18831550Grapevine Named 'SV33-82-49'April 2025October 2025Allow610NoNo
19177624Sedum Plant Named 'PPF095'April 2025August 2025Allow400NoNo
18831545Echeveria Plant Named 'OVPEARLS16'April 2025August 2025Allow400NoNo
18831535Grapevine Named 'SV36-21-170'April 2025November 2025Allow810NoNo
18831534Grapevine Named 'SV36-19-424'April 2025October 2025Allow710NoNo
19098717Achillea Plant Named 'Versred'April 2025June 2025Allow200NoNo
19093526ORNAMENTAL SWEETPOTATO PLANT NAMED ‘NCORNSP-033SCMP’March 2025August 2025Allow400NoNo
19083777Shrub Rose Plant Named 'AUSCP17960'March 2025June 2025Allow300NoNo
19067870Fragaria Plant Named 'Eves Gloria'March 2025September 2025Allow610NoNo
19065170GRAPEVINE plant named ‘SUGRA71’February 2025June 2025Allow300NoNo
19063649Ground Cover Rose Plant Named 'MEIDELVEGA'February 2025August 2025Allow500NoNo
19058226Salvia Plant Named 'Ignition Orange'February 2025September 2025Allow710NoNo
19056305Hydrangea plant named 'LC NO25'February 2025August 2025Allow610NoNo
19054797Delphinium Plant Named 'Dellas 812'February 2025May 2025Allow300NoNo
19054264PETUNIA PLANT NAMED 'DOPETPOPLUBLASA'February 2025May 2025Allow300NoNo
19054114CALIBRACHOA PLANT NAMED 'DOCALRAIPIPEPBE25'February 2025August 2025Allow610NoNo
19051480CALIBRACHOA PLANT NAMED 'DOCALALHOCO 25'February 2025August 2025Allow600NoNo
19048920Geranium Plant Named 'MVNG1905'February 2025April 2025Allow300NoNo
19048917Geranium Plant Named 'MVNG1811'February 2025April 2025Allow200NoNo
19041745GRAPEVINE PLANT NAMED ‘SUGRA69’January 2025October 2025Allow910NoNo
19041440GRAPEVINE PLANT NAMED ‘SUGRA64'January 2025August 2025Allow710NoNo
19038365Cornus Tree Named 'Rutglow'January 2025June 2025Allow510NoNo
19037279SALVIA PLANT NAMED 'DH004'January 2025July 2025Allow610NoNo
19037225SALVIA PLANT NAMED 'DH003'January 2025July 2025Allow610NoNo
19032639Philodendron plant named 'RCM2'January 2025July 2025Allow610NoNo
19030080HYDRANGEA PLANT NAMED 'HORE9103'January 2025July 2025Allow610NoNo
19026103Sorbaria Plant Named 'Hyfaria'January 2025April 2025Allow300NoNo
19025328Allium plant named 'G22087'January 2025April 2025Allow300NoNo
19022390Hibiscus plant named 'ALTobiscus'January 2025June 2025Allow510NoNo
19022478Floribunda shrub rose named 'ALTsky'January 2025July 2025Allow600NoNo
19022042PHALAENOPSIS PLANT NAMED 'PHA895502'January 2025July 2025Allow600NoNo
19021843ANTHURIUM PLANT NAMED 'AN2192908'January 2025April 2025Allow300NoNo
19019866GRAPEVINE PLANT NAMED 'BLOMG02'January 2025July 2025Allow600NoNo
19018067Ilex plant named 'FARROWICUPRT'January 2025May 2025Allow410NoNo
19017727PHALAENOPSIS PLANT NAMED 'PHA760527'January 2025April 2025Allow300NoNo
19017724PHALAENOPSIS PLANT NAMED 'PHA663401'January 2025July 2025Allow600NoNo
19006053CHRYSANTHEMUM PLANT NAMED 'G24MAG14RE'December 2024April 2025Allow300NoNo
19006070CHRYSANTHEMUM PLANT NAMED 'G24MAG16GD'December 2024July 2025Allow710NoNo
19003159HOP PLANT NAMED 'GREENMONT MOTHER'December 2024October 2025Allow1020NoNo
19000668Sansevieria plant named 'Hansoti58'December 2024March 2025Allow300NoNo
19000656Sansevieria plant named 'Hansoti57'December 2024March 2025Allow300NoNo
18989529Miniature Rose Plant Named 'KORpot132'December 2024March 2025Allow300NoNo
18831379Hosta plant named 'Humungousaurus'December 2024June 2025Allow600NoNo
18831380Hosta plant named 'Awakening Spirit'December 2024August 2025Allow810NoNo
18985322Alstroemeria plant named 'Turcal139'December 2024March 2025Allow300NoNo
18978314Philodendron Plant Named 'EM0003'December 2024May 2025Allow500NoNo
18979152Apple Tree Named 'MAC12'December 2024April 2025Allow410NoNo
18978379Camellia plant named 'FARROWCJPD'December 2024May 2025Allow510NoNo
18831361Ficus Plant Name 'ESFIMO'December 2024July 2025Allow710NoNo
18975946PHALAENOPSIS PLANT NAMED 'CEREMONY'December 2024March 2025Allow300NoNo
18966355Ribes plant named 'SMROCS'December 2024March 2025Allow300NoNo
18964952Hydrangea plant named 'SMNHAGOV'December 2024March 2025Allow300NoNo
18965006Rhododendron plant named 'NCB195'December 2024May 2025Allow510NoNo
18964990Rhododendron plant named 'NCB193'December 2024May 2025Allow510NoNo
18831342Rudbeckia plant named 'Treasure Trove'November 2024February 2025Allow300NoNo
18955822HELLEBORUS PLANT NAMED 'BORUSMURA40'November 2024February 2025Allow300NoNo
18951196GRAPEVINE PLANT NAMED 'BLOMG05'November 2024March 2025Allow410NoNo
18950498Hydrangea plant named 'LC NO23'November 2024April 2025Allow410NoNo
18947826HYBRID TEA ROSE PLANT NAMED 'WEKAMYLDRODER'November 2024February 2025Allow300NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MCCORMICK EWOLDT, SUSAN BETH.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
7
Examiner Affirmed
4
(57.1%)
Examiner Reversed
3
(42.9%)
Reversal Percentile
65.1%
Higher than average

What This Means

With a 42.9% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
35
Allowed After Appeal Filing
12
(34.3%)
Not Allowed After Appeal Filing
23
(65.7%)
Filing Benefit Percentile
56.4%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 34.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner MCCORMICK EWOLDT, SUSAN BETH - Prosecution Strategy Guide

Executive Summary

Examiner MCCORMICK EWOLDT, SUSAN BETH works in Art Unit 1661 and has examined 3,579 patent applications in our dataset. With an allowance rate of 94.5%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 14 months.

Allowance Patterns

Examiner MCCORMICK EWOLDT, SUSAN BETH's allowance rate of 94.5% places them in the 83% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by MCCORMICK EWOLDT, SUSAN BETH receive 0.53 office actions before reaching final disposition. This places the examiner in the 3% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MCCORMICK EWOLDT, SUSAN BETH is 14 months. This places the examiner in the 99% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -9.2% benefit to allowance rate for applications examined by MCCORMICK EWOLDT, SUSAN BETH. This interview benefit is in the 3% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.5% of applications are subsequently allowed. This success rate is in the 40% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 67.3% of cases where such amendments are filed. This entry rate is in the 90% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 70.8% of appeals filed. This is in the 58% percentile among all examiners. Of these withdrawals, 47.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 73.0% are granted (fully or in part). This grant rate is in the 79% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 8.5% of allowed cases (in the 91% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.2% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.